Focus on the Future 2026: New risks for internal audit in a hypervolatile decade Optro’s Focus on the Future series has chronicled the evolution of internal audit through some of the most turbulent years in recent...
Category Modules
The agentic AI playbook for internal audit
The agentic AI playbook for internal audit Autonomous controls testing: The new operating model for internal audit. The number one risk facing internal audit isn’t a control gap; it’s the risk of not using...
The agentic AI playbook for internal audit
The agentic AI playbook for internal audit Autonomous controls testing: The new operating model for internal audit. The number one risk facing internal audit isn’t a control gap; it’s the risk of not using...
Focus on the Future 2026: New risks for internal audit in a hypervolatile decade
Focus on the Future 2026: New risks for internal audit in a hypervolatile decade Optro’s Focus on the Future series has chronicled the evolution of internal audit through some of the most turbulent years in recent...
SUSE Rancher Prime O mesmo Rancher. Muito mais preparado para produção.
SUSE Rancher Prime O mesmo Rancher. Muito mais preparado para produção. O mesmo Rancher. Muito mais preparado para produção. Para ambientes que exigem mais segurança, previsibilidade e suporte, o SUSE Rancher Prime...
Gerencie e proteja sua nuvem híbrida para a próxima década
Gerencie e proteja sua nuvem híbrida para a próxima década Prepare seu ambiente cloud native para produção Reduza riscos e ganhe mais previsibilidade com uma plataforma que combina segurança, suporte empresarial e...
The power paradox: Why power infrastructure readiness will define the next wave of LNG development in North America
The power paradox: Why power infrastructure readiness will define the next wave of LNG development in North America As LNG demand grows, power infrastructure readiness is becoming a critical factor in project execution...
Assessment of Biosimilarity in mAb-based Therapeutics Using SEC-MALS
Assessment of Biosimilarity in mAb-based Therapeutics Using SEC-MALS The development and approval of biosimilar monoclonal antibody (mAb) therapeutics offers a promising path to reducing healthcare costs and increasing...
Sartorius Stedim BioOutsource Increases Value for its Clients with Biopharmaceutical Platform Solution with UNIFI
Sartorius Stedim BioOutsource Increases Value for its Clients with Biopharmaceutical Platform Solution with UNIFI Adds Structural Characterization of Novel Monoclonal Antibodies and Biosimilars by LC-MS to Testing...
PH1001: The Role of Multi-Angle Light Scattering in Biosimilar Characterization and Approval
PH1001: The Role of Multi-Angle Light Scattering in Biosimilar Characterization and Approval Bringing a biotherapeutic from the laboratory to the market is a complex and highly regulated process. The approval pathway...